392 related articles for article (PubMed ID: 29157179)
1. Association between false-positive TORCH and antiphospholipid antibodies in healthy pregnant women.
De Carolis S; Tabacco S; Rizzo F; Perrone G; Garufi C; Botta A; Salvi S; Benedetti Panici P; Lanzone A
Lupus; 2018 Apr; 27(5):841-846. PubMed ID: 29157179
[TBL] [Abstract][Full Text] [Related]
2. The relationship between TORCH complex false positivity and obstetric outcome in patients with antiphospholipid syndrome.
De Carolis S; Santucci S; Botta A; Salvi S; Degennaro VA; Garufi C; Garofalo S; Ferrazzani S; Scambia G
Lupus; 2012 Jun; 21(7):773-5. PubMed ID: 22635229
[TBL] [Abstract][Full Text] [Related]
3. Screening cytomegalovirus, rubella and toxoplasma infections in pregnant women with unknown pre-pregnancy serological status.
Karacan M; Batukan M; Cebi Z; Berberoglugil M; Levent S; Kır M; Baksu A; Ozel E; Camlıbel T
Arch Gynecol Obstet; 2014 Dec; 290(6):1115-20. PubMed ID: 25027818
[TBL] [Abstract][Full Text] [Related]
4. False-positive IgM for CMV in pregnant women with autoimmune disease: a novel prognostic factor for poor pregnancy outcome.
De Carolis S; Santucci S; Botta A; Garofalo S; Martino C; Perrelli A; Salvi S; Degennaro V; de Belvis A; Ferrazzani S; Scambia G
Lupus; 2010 Jun; 19(7):844-9. PubMed ID: 20305050
[TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
[TBL] [Abstract][Full Text] [Related]
6. [Usefulness of determining low-avidity IgG antibodies in the diagnosis of primary rubella infection in pregnant women].
Lafarga B; Noguera FJ; Pérez MC; Copado R; García A; Soria E
Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):413-8. PubMed ID: 9887628
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of torch infections and its associated poor outcome in high-risk pregnant women of Central India: Time to think for prevention strategies.
Manjunathachar HV; Singh KN; Chouksey V; Kumar R; Sharma RK; Barde PV
Indian J Med Microbiol; 2020; 38(3 & 4):379-384. PubMed ID: 33154250
[TBL] [Abstract][Full Text] [Related]
8. Seasonal influence on TORCH infection and analysis of multi-positive samples with indirect immunofluorescence assay.
Chen L; Liu J; Shi L; Song Y; Song Y; Gao Y; Dong Y; Li L; Shen M; Zhai Y; Cao Z
J Clin Lab Anal; 2019 May; 33(4):e22828. PubMed ID: 30666721
[TBL] [Abstract][Full Text] [Related]
9. Maternal immunoglobulin G avidity as a diagnostic tool to identify pregnant women at risk of congenital cytomegalovirus infection.
Kaneko M; Ohhashi M; Minematsu T; Muraoka J; Kusumoto K; Sameshima H
J Infect Chemother; 2017 Mar; 23(3):173-176. PubMed ID: 28034524
[TBL] [Abstract][Full Text] [Related]
10. Is screening of TORCH worthwhile in women with bad obstetric history: an observation from eastern Nepal.
Kumari N; Morris N; Dutta R
J Health Popul Nutr; 2011 Feb; 29(1):77-80. PubMed ID: 21528793
[TBL] [Abstract][Full Text] [Related]
11. TORCH infection in women with bad obstetric history--a pilot study in Kumaon region.
Thapliyal N; Shukla PK; Kumar B; Upadhyay S; Jain G
Indian J Pathol Microbiol; 2005 Oct; 48(4):551-3. PubMed ID: 16366124
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between TORCH infections and abnormal pregnant outcomes].
Zhang QQ; Cheng JZ; Wang FH
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Apr; 25(2):209-10. PubMed ID: 23894850
[TBL] [Abstract][Full Text] [Related]
13. Association between TORCH infection and lupus anticoagulant antibody in pregnant women with recurrent abortion.
Fatah HR
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(13):162-166. PubMed ID: 38158672
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of toxoplasmosis, rubella, cytomegalovirus, and herpes (TORCH) infections among women attending the antenatal care clinic, maternity hospital in Abha, Southwestern Saudi Arabia.
Al-Hakami AM; Paul E; Al-Abed F; Alzoani AA; Shati AA; Assiri MI; Qasim AA; Riaz F; Moosa RA; Chandramoorthy HC
Saudi Med J; 2020 Jul; 41(7):757-762. PubMed ID: 32601646
[TBL] [Abstract][Full Text] [Related]
15. TORCH serologies and specific IgM antibody determination in acquired and congenital infections.
Fung JC; Tilton RC
Ann Clin Lab Sci; 1985; 15(3):204-11. PubMed ID: 2986514
[TBL] [Abstract][Full Text] [Related]
16. TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China.
Wang LC; Yan F; Ruan JX; Xiao Y; Yu Y
BMC Pregnancy Childbirth; 2019 Dec; 19(1):484. PubMed ID: 31818265
[TBL] [Abstract][Full Text] [Related]
17. TORCH Infections. Toxoplasmosis, Other (syphilis, varicella-zoster, parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes infections.
Stegmann BJ; Carey JC
Curr Womens Health Rep; 2002 Aug; 2(4):253-8. PubMed ID: 12150751
[TBL] [Abstract][Full Text] [Related]
18. [Detection the serum IgM and IgG specific for TORCH in 1307 women in the period of pre-pregnancy and pregnancy].
Qin W; Hu DC; Pang HL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Aug; 25(4):292-4. PubMed ID: 22097611
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome.
Zhang S; Wu Z; Li J; Wen X; Li L; Zhang W; Zhao J; Zhang F; Li Y
Clin Rheumatol; 2017 Feb; 36(2):407-412. PubMed ID: 28000012
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of Toxoplasma and CMV serology and of GBS colonization in pregnancy and neonatal outcome in a Sicilian population.
Puccio G; Cajozzo C; Canduscio LA; Cino L; Romano A; Schimmenti MG; Giuffrè M; Corsello G
Ital J Pediatr; 2014 Feb; 40():23. PubMed ID: 24559197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
